Development of a new quantitative RT-PCR to detect lymphocytic choriomeningitis virus

Laura Herrero1,2, Nuria Labiod1,2, Francisca Molero1

  • 1Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.

PubMed

Insights

A new quantitative reverse transcription polymerase chain reaction (RT-qPCR) method effectively detects all Lymphocytic choriomeningitis virus (LCMV) strains. This advancement improves diagnostic accuracy and epidemiological surveillance for this neglected zoonotic virus.

Area of Science:

  • Virology
  • Molecular Biology
  • Public Health

Background:

  • Lymphocytic choriomeningitis virus (LCMV) is a globally distributed, neglected virus transmitted by rodents.
  • Mice (Mus musculus) serve as reservoirs and vectors, posing risks to research and human populations.
  • Existing LCMV diagnostic tools require improvement for enhanced detection and surveillance.

Purpose of the Study:

  • To develop and validate a novel quantitative reverse transcription polymerase chain reaction (RT-qPCR) assay for LCMV detection.
  • To ensure the assay can identify all known LCMV strains and lineages.
  • To enhance diagnostic capabilities for LCMV surveillance in both animal models and humans.

Main Methods:

  • Development of an RT-qPCR assay targeting the S segment of the LCMV genome.
  • Evaluation of the assay's specificity, sensitivity, and limit of detection (LOD).
  • Inclusion of an internal amplification control to identify false negatives.

Main Results:

  • The developed RT-qPCR method successfully detected all five known LCMV lineages.
  • The assay demonstrated a low limit of detection (LOD) of 5.6 genome copies/μL.
  • The method showed no cross-reactivity with other arenaviruses and included an internal control for result validation.

Conclusions:

  • A highly sensitive and specific RT-qPCR assay for LCMV detection has been successfully designed and validated.
  • This new diagnostic tool can improve the speed and accuracy of LCMV diagnosis.
  • The validated assay will aid in enhanced epidemiological surveillance of LCMV in humans and animals.